Response to Letter to the Editor Regarding OpT2mise Study

被引：0
|
作者：
Conget, Ignacio [1 ]
Aronson, Ronnie [2 ]
Cohen, Ohad
Reznik, Yves [3 ]
机构：
[1] Univ Hosp Clin, Endocrinol & Nutr Dept, Diabet Unit, Villarroel 170, Barcelona 08036, Spain
[2] LMC Diabet & Endocrinol, Toronto, ON, Canada
[3] Univ Caen, Cote de Nacre Reg Hosp Ctr, Dept Endocrinol, Caen, France
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2016年 / 18卷 / 07期
关键词：
D O I：
10.1089/dia.2016.0081
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：449 / 449
页数：1
相关论文
共 50 条
  • [1] OpT2mise trial
    Kang, Seema
    LANCET DIABETES & ENDOCRINOLOGY, 2014, 2 (08): : 615 - 615
  • [2] Comment on Publications from OpT2mise Study
    Milenkovic, Tatjana
    Kocova, Mirjana
    Krstevska, Brankica
    Pemovska, Gordana
    Smokovski, Ivica
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 (07) : 446 - 447
  • [3] Efficacy and safety of insulin pump therapy in type 2 diabetes: the OpT2mise study
    Reznik, Y.
    Cohen, O.
    Aronson, R.
    Runzis, S.
    Castaneda, J.
    De Portu, S.
    Lee, S.
    Conget, I.
    DIABETOLOGIA, 2014, 57 : S410 - S411
  • [4] Efficacy and Safety of Insulin Pump Therapy in Type 2 Diabetes: The OpT2mise Study
    Aronson, Ronnie
    Reznik, Yves
    Conget, Ignacio
    Runzis, Sarah
    Castaneda, Javier
    De Portu, Simone
    Lee, Scott
    Cohen, Ohad
    DIABETES, 2015, 64 : A270 - A271
  • [5] EFFICACY AND SAFETY OF INSULIN PUMP THERAPY IN TYPE 2 DIABETES: OPT2MISE STUDY - FULL STUDY REPORT
    Aronson, R.
    Reznik, Y.
    Conget, I.
    Runzis, S.
    De Portu, S.
    Lee, S.
    Castaneda, J.
    Cohen, O.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 : A41 - A41
  • [6] Factors affecting the Insulin Dose Adaptation in Patients with Diabetes Mellitus Type 2: an Analysis from the OpT2mise Study
    Schuetz-Fuhrmann, Ingrid
    Reznik, Yves
    Aronson, Ronnie
    Conget, Ignacio
    Liabat, Severine
    Prager, Rudolf
    Castaneda, Javier
    Cohen, Ohad
    WIENER KLINISCHE WOCHENSCHRIFT, 2016, 128 : S401 - S401
  • [7] The Impact of Insulin Pump Therapy on Glycemic Profiles in Patients with Type 2 Diabetes: Data from the OpT2mise Study
    Conget, Ignacio
    Castaneda, Javier
    Petrovski, Goran
    Guerci, Bruno
    Racault, Anne-Sophie
    Reznik, Yves
    Cohen, Ohad
    Runzis, Sarah
    de Portu, Simona
    Aronson, Ronnie
    DIABETES TECHNOLOGY & THERAPEUTICS, 2016, 18 (01) : 22 - 28
  • [8] OpT2mise study: the impact of insulin pump therapy on treatment satisfaction and resource utilisation in patients with type 2 diabetes
    Aronson, R.
    Cohen, O.
    Conget, I.
    de Portu, S.
    Racault, A-S.
    Shin, J.
    Reznik, Y.
    DIABETOLOGIA, 2014, 57 : S415 - S415
  • [9] OPT2MISE STUDY: THE IMPACT OF INSULIN PUMP THERAPY ON TREATMENT SATISFACTION AND RESOURCE UTILIZATION IN PATIENTS WITH TYPE 2 DIABETES
    Aronson, R.
    De Portu, S.
    Cohen, O.
    Conget, I.
    Racault, A. S.
    Shin, J.
    Runzis, S.
    Reznik, Y.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A11 - A11
  • [10] The impact of insulin pump therapy on glycaemic profile of patients with type 2 diabetes: data from the OpT2mise study
    Conget, I.
    Cohen, O.
    Aronson, R.
    Castaneda, J.
    Re, R.
    Shin, J.
    Reznik, Y.
    DIABETOLOGIA, 2014, 57 : S416 - S416
12345